XmAb20717
Showing 1 - 7 of 7
Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)
Not yet recruiting
- Colorectal Cancer
- +2 more
- Regorafenib
- XmAb20717
-
Houston, TexasM D Anderson Cancer Center
May 31, 2023
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta
Not yet recruiting
- Castration-Sensitive Prostate Carcinoma
- +2 more
- Abiraterone
- +9 more
-
Atlanta, Georgia
- +1 more
Feb 8, 2023
Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland
Not yet recruiting
- Locally Advanced Thyroid Gland Anaplastic Carcinoma
- +2 more
-
Chicago, Illinois
- +1 more
Jul 7, 2022
Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)
Recruiting
- Microsatellite High Cancers
- +7 more
- XmAb20717
-
Houston, TexasM D Anderson Cancer Center
Aug 8, 2022
Biliary Tract Cancer Trial in Philadelphia (XmAb20717)
Recruiting
- Biliary Tract Cancer
- XmAb20717
-
Philadelphia, PennsylvaniaAbramson Cancer Center at University of Pennsylvania
Apr 11, 2022
Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- XmAb20717 + carboplatin + cabazitaxel
- +2 more
-
Duarte, California
- +9 more
May 24, 2022
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022